From the Guidelines
Viagra (sildenafil) can be safely used after Coronary Artery Bypass Grafting (CABG) surgery, but only after clearance from a cardiologist, typically around 6-8 weeks post-operation, as recommended by the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP) 1. When considering the use of Viagra after CABG, it's crucial to prioritize the patient's cardiac health and potential interactions with other medications.
- The patient should not be taking nitrate medications like nitroglycerin for chest pain, as this combination can cause a dangerous drop in blood pressure.
- The typical starting dose after CABG is 25-50mg taken approximately one hour before sexual activity, with a maximum of one dose per day.
- It's essential to consult with a cardiologist to ensure it's appropriate for the patient's specific situation, as Viagra can cause blood pressure to drop, which may be problematic for some cardiac patients.
- Many CABG patients successfully resume using Viagra after recovery, but individual medical circumstances vary, so professional medical guidance is essential, as emphasized by the European Heart Journal study 1. Key factors to consider when resuming sexual activity after CABG include:
- The sternotomy should be well healed
- The patient should be cleared for physical activity and sexual function by their cardiac surgeon
- The patient should be encouraged to participate in cardiac rehabilitation to support physical activity and sexual function, as recommended by the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP) 1.
From the Research
Safety of Using Viagra (Sildenafil) after Coronary Artery Bypass Grafting (CABG)
- The safety of using sildenafil after CABG is a concern due to the potential risk of precipitating myocardial infarction or death during sexual activity 2.
- However, studies have shown that sildenafil is safe to use in patients with stable angina, controlled on medications, and those with coronary artery disease who are not taking nitrates 2, 3.
- A study found that sildenafil significantly improves erectile function and is well tolerated in patients with erectile dysfunction and ischemic heart disease who are not taking nitrate therapy 3.
- Another study compared the use of trimetazidine plus sildenafil to chronic nitrates in controlling myocardial ischemia during sexual activity in patients with coronary artery disease, and found that combination therapy with sildenafil and trimetazidine is more effective than nitrate therapy in controlling ischemic episodes during sexual activity 4.
Considerations for Patients after CABG
- Patients who have undergone CABG should be aware of the potential risks associated with sexual activity, and clinicians should consider the patient's cardiovascular status before initiating any treatment for erectile dysfunction 2, 3.
- The use of nitrates is a contraindication to the use of sildenafil, and alternative therapies such as trimetazidine may be considered in patients who require treatment for erectile dysfunction 4.
- Secondary prevention after CABG is essential to reduce the risk of recurrent adverse ischemic events and other cardiovascular outcomes, and novel pharmacological preventive strategies may be beneficial in addressing residual cardiovascular risk 5.